Target intelligence / Profile preview

Vibrio cholerae epidemic-strain surface receptors

Molecular classification
Other
01

Overview

Vibrio cholerae epidemic-strain surface receptors refer to the primary surface-exposed molecules of pathogenic V. cholerae strains, specifically the O1 and O139 serogroups, which are responsible for epidemic and pandemic cholera (Medscape, 2025). The most critical of these are the O-antigen (a component of the lipopolysaccharide) and the toxin-coregulated pilus (TCP) (NIH, 2024). The O-antigen defines the serogroup and is the primary target for the host's protective immune response, particularly vibriocidal antibodies (Wikipedia, 2024). TCP is a type IV pilus essential for the bacterium's ability to colonize the human small intestine by mediating inter-bacterial adhesion and attachment to the host epithelium (PLOS Pathogens, 2018). Furthermore, TCP serves as the essential surface receptor for the CTXφ bacteriophage, which carries the genes for the cholera toxin (ASM, 2024). These surface components are the primary targets for current oral cholera vaccines and are being investigated as targets for novel anti-adhesion and anti-virulence therapeutics designed to prevent colonization and disease transmission (NIH, 2024).

Other names
Vibrio cholerae surface antigensO-antigenToxin-coregulated pilusTCPLipopolysaccharideLPSO1 antigenO139 antigen
02

Mechanism of action

Vaccines induce protective vibriocidal antibodies against the O-antigen to prevent colonization and infection; small molecule inhibitors like virstatin suppress the expression of the toxin-coregulated pilus (TCP) and cholera toxin by targeting regulatory proteins.

03

Biological functions

AdhesionColonizationPathogenesisImmune response
04

Disease associations

Infection
05

Safety considerations

Potential for serogroup switching (e.g., O1 to O139) which can lead to vaccine escapeMild gastrointestinal side effects from oral vaccinesDevelopment of resistance to anti-virulence agents
06

Interacting drugs

Vaxchora

4 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerO-antigen serotype (O1 or O139)TCP expression levels

Beyond the preview

Go deeper on Vibrio cholerae epidemic-strain surface receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae epidemic-strain surface receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call